Novartis pursues PBS listing for Beovu  

Novartis is working to ensure its newly-approved drug Beovu is accessible via the Pharmaceutical Benefits Scheme (PBS) at the earliest opportunity after expressing disappointment over an initial decision not to recommend it for the government-subsidised medicines program. Read more

Specsavers reaches 400-store milestone

Specsavers is celebrating the opening of its 400th store across Australia and New Zealand this week, in a major milestone for the optical chain since its arrival to the local ophthalmic market 12 years ago. Read more